Paradigm Oncology

Paradigm Oncology Paradigm Oncology is dedicated to helping glioblastoma multiforme (GBM) patients, and their neuro-on

Paradigm Diagnostics is a clinical laboratory focused on targeted profile tests to identify the best therapy options for patients with Glioblastoma and other cancers of the brain.

01/25/2013

Brain Tumor (Meningioma) Gene Finding May Point Way to Precision Drug http://t.co/alCIn2Bz via

01/22/2013

Renowned GBM expert, Dr. Michael Reardon, M.D., of the Dana Farber Cancer Institute, has joined Paradigm Oncology's advisory board.

01/18/2013

Mayo Clinic - Mayo Clinic Researchers Identify Enzyme (KLK6) Involved in Deadly Brain Tumors - http://t.co/MV8ZEnH2

01/10/2013

Smaller Radiation Fields Can Spare Brain When Treating Tumors - Wake Forest Baptist Medical Center http://t.co/HNBZuQXC via

Paradigm Oncology still needs your help to achieve our mission for improving glioblastoma (brain cancer) patient care!! ...
08/11/2012

Paradigm Oncology still needs your help to achieve our mission for improving glioblastoma (brain cancer) patient care!! Please support us by donating today to our "crowd funding" campaign at: http://www.indiegogo.com/paradigm-oncology

Bringing the Promise of Personalized Medicine to Glioblastoma (GBM) Patients.

The recent discovery of another fusion protein mutation that is a driver of some glioblastomas (the FGFR kinase mutant –...
08/05/2012

The recent discovery of another fusion protein mutation that is a driver of some glioblastomas (the FGFR kinase mutant – see http://www.genomeweb.com//node/1111531?hq_e=el&...) is a great example of why tumor-profiling for GBM is so important and so necessary.

Patient that harbor this fusion mutant (about 3% of patients) may be likely to respond to targeted inhibitors of FGFR. However, we can’t identify those patients from the entire GBM patient population without testing all patients for this tumor driver. The same thing is true for other well-known tumor drivers, such as the EGFR kinase extra-cellular mutants, and others.

GBM-specific tumor-profiling will be an important step forward in identify the best potential therapy options for GBM patients on a patient-by-patient basis.

Please help Paradigm Oncology achieve our mission of creating such a test for GBM patients by donating to our campaign at:
http://www.indiegogo.com/paradigm-oncology

New York City Mayor Michael Bloomberg stopped by the new site of the New York Genome Center at 101 Sixth Avenue in Manhattan on Tuesday. While the center did lose out on the $100 million genius school grant last year, Bloomberg dug into his own deep coffers and offered up $2.5 million to help establ...

06/26/2012

Go to www.paradigmoncology.com to learn more about our effort to help patient with Glioblastoma

Bringing the Promise of Personalized Medicine to Glioblastoma Patients

Address

Danvers, MA

Alerts

Be the first to know and let us send you an email when Paradigm Oncology posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share